Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence ofin vivoactivation in active disease
Open Access
- 1 December 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 86 (3) , 489-493
- https://doi.org/10.1111/j.1365-2249.1991.tb02958.x
Abstract
Morphological evidence of activation in vivo of circulating neutrophils in patients with inflammatory bowel disease (IBD) was sought by quantitative light microscope examination of toluidine bluestained leucocyte preparations made from peripheral venous bloods that had been fixed immediately ex vivo. The proportion of spherical (unactivated) circulating neutrophils was reduced in active Crohn's disease (73%; 46–96 (median; range), n= 11) compared with inactive Crohn's (90%; 45–99; n= 18, Pn=13, Pn= 17) than in quiescent colitis (88%; 57–99, n= 13, PP<0.05). Activated neutrophils occur in the circulating pool of patients with active IBD and can be detected by light microscopy of peripheral venous blood leucocyte preparations.Keywords
This publication has 24 references indexed in Scilit:
- Adhesion receptors of the immune systemNature, 1990
- Leukocyte adhesion to endothelium in inflammationCell, 1990
- Neutrophil Mac-1 and MEL-14 Adhesion Proteins Inversely Regulated by Chemotactic FactorsScience, 1989
- Locomotion and chemotaxis of leukocytes: gradient perception and locomotor capacityCurrent Opinion in Immunology, 1988
- Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.Journal of Clinical Pathology, 1988
- Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.Gut, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- INDIUM-111 TAGGED LEUCOCYTES IN THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASEThe Lancet, 1981
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.Journal of Clinical Investigation, 1977